Lv11
34 积分 2025-03-04 加入
Proteomic and metabolomic features in patients with HCC responding to lenvatinib and anti-PD1 therapy
3小时前
待确认
No evidence for increased platelet activation in patients with hepatitis B- or C-related cirrhosis and hepatocellular carcinoma
3小时前
已完结
By inhibiting PFKFB3, aspirin overcomes sorafenib resistance in hepatocellular carcinoma
7天前
已完结
NLRP6 deficiency enhances macrophage-mediated phagocytosis via E-Syt1 to inhibit hepatocellular carcinoma progression
22天前
已完结
Platelet activation during chronic hepatitis B infection exacerbates liver inflammation and promotes fibrosis
2个月前
已完结
Comparison of the efficacy and safety of TACE-HAIC-MTTs-ICIs and TACE-MTTs-ICIs in the hepatocellular carcinoma: a prognostic analysis based on the dynamic changes of serum AFP
2个月前
已完结
Safety/efficacy of atezolizumab + bevacizumab during anti-platelet/anticoagulation therapy in unresectable hepatocellular carcinoma
2个月前
已完结
Platelet activation during chronic hepatitis B infection exacerbates liver inflammation and promotes fibrosis
2个月前
已完结
Role of CD61 low-density neutrophils in promoting hepatocellular carcinoma metastasis through CCDC25 upregulation
2个月前
已完结
Platelet Function Decreases with Increasing Severity of Liver Cirrhosis and Portal Hypertension-A Prospective Study
2个月前
已完结
皖公网安备34019202002308
